Remedy Meds

What it is

Clinicians are available by video, chat and messaging, and medications ship from US pharmacies.

Options include compounded semaglutide and tirzepatide, a twice-weekly half-dose 'microdose' plan, and brand-name Ozempic and Zepbound at retail pricing.

Prices are shown after an online quiz.

Prescribes: Compounded semaglutide and tirzepatide (not FDA-approved) and brand-name Ozempic and Zepbound.

By the numbers

• Trustpilot 4.6/5 from 13,788 reviews (6% 1-star; checked 2026-10-15).5
• BBB: F; not BBB Accredited; 486 complaints in the last 3 years (checked 2026-10-15).6

Pros and cons

What users say

Common themes in public posts on Reddit, Trustpilot, the Better Business Bureau and app stores, summarised and linked. Individual experiences vary.

• Reviewers often describe attentive clinicians, easy reordering and timely deliveries.3
• Complaints include shipping delays leaving people without medication, slow support and price changes at checkout.3
• Reddit members repeatedly describe Remedy Meds as expensive, citing about $399-$400 a month for compounded tirzepatide in 2025-2026, and many say they moved to cheaper flat-price providers after the first months.78
• Some members found Remedy a supportive place to start because of its clinician visits, while others report poor customer service, billing frustrations and slow responses.7910
• Members discussed Remedy's 2025 switch to compounded tirzepatide mixed with added ingredients (NAD and B12) at slightly non-standard doses, and some found the dosing confusing; one member said its sublingual form did not work for them.111213
• Trustpilot reviewers praise attentive clinicians, easy online ordering and timely, well-packed deliveries; complaints mention delivery to an old address, mixed answers from different staff and a price that rose at checkout.5

Records we found

Official and court records we found in public sources as of October 15, 2026. This is not a live or complete record; check fda.gov, ftc.gov and court sites for the latest.

1. Sep 2025
   FDA

   FDA sent a warning letter dated September 9, 2025 to Remedy Meds as part of its batch of letters to telehealth firms over false or misleading claims about compounded GLP-1 products.2